$4.27
4.15% yesterday
Nasdaq, Oct 03, 10:00 pm CET

Applied DNA Sciences, Inc. Stock price

$4.27
+1.34 45.73% 1M
-20.63 82.85% 6M
-148.73 97.21% YTD
-272.86 98.46% 1Y
-16,795.73 99.97% 3Y
-112,495.73 100.00% 5Y
-3,557,995.73 100.00% 10Y
+3.77 754.00% 20Y
Nasdaq, Closing price Fri, Oct 03 2025
+0.17 4.15%

Key metrics

Basic
Market capitalization
$5.5m
Enterprise Value
$780.0k
Net debt
positive
Cash
$4.7m
Shares outstanding
900.0k
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.7 | 1.0
EV/Sales
0.2 | 0.1
EV/FCF
negative
P/B
0.8
Financial Health
Equity Ratio
71.5%
Return on Equity
-79.0%
ROCE
-169.7%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$3.3m | $5.4m
EBITDA
$-13.1m | -
EBIT
$-13.4m | $-11.9m
Net Income
$-67.5m | $-330.5m
Free Cash Flow
$-13.3m
Growth (TTM | estimate)
Revenue
-2.9% | 57.1%
EBITDA
6.6% | -
EBIT
10.3% | 15.1%
Net Income
-797.7% | -4,471.0%
Free Cash Flow
6.9%
Margin (TTM | estimate)
Gross
39.6%
EBITDA
-396.0% | -
EBIT
-406.1%
Net
-2,047.4% | -6,131.4%
Free Cash Flow
-402.2%
More
EPS
$-118.0
FCF per Share
$-14.7
Short interest
15.2%
Employees
47
Rev per Employee
$70.0k
Show more

Is Applied DNA Sciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Applied DNA Sciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Applied DNA Sciences, Inc. forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Applied DNA Sciences, Inc. forecast:

Hold
50%
Sell
50%

Financial data from Applied DNA Sciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
3.30 3.30
3% 3%
100%
- Direct Costs 1.99 1.99
22% 22%
60%
1.31 1.31
54% 54%
40%
- Selling and Administrative Expenses 11 11
7% 7%
340%
- Research and Development Expense 3.46 3.46
6% 6%
105%
-13 -13
7% 7%
-396%
- Depreciation and Amortization 0.33 0.33
65% 65%
10%
EBIT (Operating Income) EBIT -13 -13
10% 10%
-406%
Net Profit -68 -68
798% 798%
-2,046%

In millions USD.

Don't miss a Thing! We will send you all news about Applied DNA Sciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Applied DNA Sciences, Inc. Stock News

Neutral
Business Wire
5 days ago
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a biotechnology company focused on providing nucleic acid production solutions, today announced up to $58 million in commitments for a private investment in public equity (“PIPE”) offering led by institutional investors to initiate a digital asset treasury strategy based on BNB, the n...
Neutral
Accesswire
11 days ago
STONY BROOK, NY / ACCESS Newswire / September 23, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, announced that members of its business development and technical teams will be in attendance at upcoming industry conferences and pr...
Neutral
Accesswire
about 2 months ago
STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, today reported financial results for its third quarter of fiscal 2025 ended June 30, 2025. The Company's Form 10-Q for its fiscal third...
More Applied DNA Sciences, Inc. News

Company Profile

Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Head office United States
CEO James Hayward
Employees 47
Founded 1983
Website adnas.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today